Versant Ventures VI GP, L.P. insider trades: LENZ Therapeutics (LENZ) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Versant Ventures VI GP, L.P. reports to the SEC
and 6 more companies
Open-market buys and sales
35 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | LENZ | ↓ Sell | 132,944 | $46.01 | $6.1M | Direct | Oct 2, 2025 (2d) |
| Sep 30, 2025 | LENZ | ↓ Sell | 92,030 | $46.01 | $4.2M | Indirect | Oct 2, 2025 (2d) |
| Sep 19, 2025 | LVTX | ↓ Sell | 2,370,533 | $1.40 | $3.3M | Direct | Sep 23, 2025 (4d) |
| Sep 19, 2025 | LVTX | ↓ Sell | 532,870 | $1.40 | $747K | Indirect | Sep 23, 2025 (4d) |
| Sep 18, 2025 | LENZ | ↓ Sell | 90,654 | $42.23 | $3.8M | Direct | Sep 22, 2025 (4d) |
| Sep 18, 2025 | LENZ | ↓ Sell | 44,650 | $42.23 | $1.9M | Indirect | Sep 22, 2025 (4d) |
| Sep 18, 2025 | LVTX | ↓ Sell | 1,036,624 | $1.49 | $1.5M | Direct | Sep 18, 2025 (0d) |
| Sep 18, 2025 | LVTX | ↓ Sell | 647,810 | $1.49 | $962K | Indirect | Sep 18, 2025 (0d) |
| Aug 26, 2025 | LENZ | ↓ Sell | 126,023 | $39.47 | $5.0M | Direct | Aug 26, 2025 (0d) |
| Aug 26, 2025 | LENZ | ↓ Sell | 62,071 | $39.47 | $2.4M | Indirect | Aug 26, 2025 (0d) |
| Aug 18, 2025 | LENZ | ↓ Sell | 175,679 | $39.34 | $6.9M | Direct | Aug 19, 2025 (1d) |
| Aug 18, 2025 | LENZ | ↓ Sell | 85,034 | $39.33 | $3.3M | Indirect | Aug 19, 2025 (1d) |
| Jul 10, 2025 | LENZ | ↓ Sell | 191,376 | $34.00 | $6.5M | Direct | Jul 14, 2025 (4d) |
| Jun 27, 2025 | LENZ | ↓ Sell | 200,000 | $30.46 | $6.1M | Direct | Jul 1, 2025 (4d) |
| Jun 20, 2025 | LENZ | ↓ Sell | 200,877 | $30.15 | $6.1M | Indirect | Jun 20, 2025 (0d) |
| Jun 20, 2025 | LENZ | ↓ Sell | 133,924 | $30.25 | $4.1M | Direct | Jun 20, 2025 (0d) |
| Jun 10, 2025 | LENZ | ↓ Sell | 350,000 | $29.00 | $10.2M | Indirect | Jun 12, 2025 (2d) |
| Oct 29, 2024 | GLUE | ↓ Sell | 157,895 | $9.44 | $1.5M | Indirect | Oct 30, 2024 (1d) |
| Sep 20, 2024 | GLUE | ↓ Sell | 1,132,566 | $6.53 | $7.4M | Direct | Sep 24, 2024 (4d) |
| Sep 13, 2024 | GLUE | ↓ Sell | 567,213 | $6.00 | $3.4M | Direct | Sep 13, 2024 (0d) |
| Aug 12, 2024 | TPST | ↓ Sell | 787,999 | $1.23 | $967K | Direct | Aug 12, 2024 (0d) |
| Aug 9, 2022 | IPSC | ↓ Sell | 550,000 | $13.03 | $7.2M | Direct | Aug 11, 2022 (2d) |
| Jun 3, 2022 | RPTX | ↓ Sell | 750,000 | $12.25 | $9.2M | Indirect | Jun 7, 2022 (4d) |
| Oct 18, 2021 | OYST | ↓ Sell | 550,000 | $14.84 | $8.2M | Indirect | Oct 20, 2021 (2d) |
| Jun 29, 2021 | GRPH | ↑ Buy | 180,000 | $17.00 | $3.1M | Indirect | Jul 1, 2021 (2d) |
| Jun 28, 2021 | GLUE | ↑ Buy | 157,895 | $19.00 | $3.0M | By Versant Vantage I, L.P. | Jun 30, 2021 (2d) |
| Jun 22, 2021 | IPSC | ↑ Buy | 100,000 | $20.00 | $2.0M | Indirect | Jun 23, 2021 (1d) |
| Jun 23, 2020 | RPTX | ↑ Buy | 250,000 | $20.00 | $5.0M | Indirect | Jun 25, 2020 (2d) |
| Mar 3, 2020 | PASG | ↑ Buy | 225,000 | $18.00 | $4.0M | By Versant Vantage I, L.P. | Mar 3, 2020 (0d) |
| Jan 21, 2020 | AKRO | ↓ Sell | 59,532 | $20.87 | $1.2M | Indirect | Jan 21, 2020 (0d) |
| Jan 15, 2020 | AKRO | ↓ Sell | 50,837 | $20.04 | $1.0M | Indirect | Jan 15, 2020 (0d) |
| Jan 9, 2020 | AKRO | ↓ Sell | 53,057 | $19.99 | $1.1M | Indirect | Jan 9, 2020 (0d) |
| Jan 6, 2020 | AKRO | ↓ Sell | 72,444 | $19.70 | $1.4M | Indirect | Jan 6, 2020 (0d) |
| Nov 4, 2019 | OYST | ↑ Buy | 465,000 | $16.00 | $7.4M | Indirect | Nov 4, 2019 (0d) |
| Nov 4, 2019 | OYST | ↑ Buy | 125,000 | $16.00 | $2.0M | Direct | Nov 4, 2019 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other LENZ insiders
Open-market trades in the last 12 months
About Versant Ventures VI GP, L.P.'s insider trades
Versant Ventures VI GP, L.P. is an insider at LENZ Therapeutics (LENZ). Since Nov 4, 2019, it has reported 7 open-market purchases worth $26.6M and 28 sales worth $115.7M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include other transactions (20 filings), conversions (8 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every LENZ insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.